Publisher： John Wiley & Sons Inc
E-ISSN： 1445-5994|45|7|748-756
ISSN： 1444-0903
Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.7, 2015-07, pp. : 748-756
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractBackground/AimTo determine the diagnostic and prognostic utility of high‐sensitive troponin assays in the very early phase of acute myocardial infarction (AMI) (less than 3 h since symptoms onset) by performing a meta‐analysis of prospective studies.MethodsRelevant studies were identified by searches of MEDLINE and Elsevier Sciencedirect until 31 January 2014 and by reviewing the reference lists from retrieved articles. Prospective studies that reported diagnostic utility in AMI using both high‐sensitive troponin assays and conventional cardiac troponin, and reported the estimates of hazard ratio (HR) with 95% confidence intervals (CI) for prognostic utility were included. Data were extracted independently by two authors and summary estimates of association were obtained using a random effects model.ResultsOf the seven studies included, four studies reported the diagnostic utility of high‐sensitive troponin assays (2863 patients) and three reported the prognostic utility in AMI (2329 patients). Within 12 h of symptoms onset, the pooled sensitivity and specificity of high‐sensitive troponin assays were 0.89 (95% CI 0.85–0.91) and 0.89 (95% CI 0.85–0.92), respectively, and within 3 h, the pooled sensitivity and specificity of high‐sensitive troponin assays were 0.79 (95% CI 0.71–0.85) and 0.92 (95% CI 0.88–0.96) respectively. Compared with conventional cardiac troponin assays, the high‐sensitive troponin assays had higher sensitivity (0.89 vs 0.72) but lower specificity (0.89 vs 0.95) in diagnosing AMI within 12 h of symptoms onset. Within 3 h, the sensitivity of high‐sensitive troponin assays was still higher (0.79 vs 0.59), but the specificity was almost the same (0.92 vs 0.95) as that of conventional troponin assays. The elevated high‐sensitive troponin assays had an overall pooled HR of 2.66 (95% CI 1.31–5.44) and 2.14 (95% CI 1.15–3.98) for the end‐points of death and non‐fatal AMI respectively.ConclusionsThese findings provide quantitative data supporting high‐sensitive troponin assays having early diagnostic and prognostic utility in AMI.
Related content
Access to resources
Recommend
BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 6, 2015-12 ,pp. :